Pfizer Inc.
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS
Last updated:
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2020
Issue date:
11 Jun 2020